Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospective observational cohort study
卡培他滨或5-氟尿嘧啶类药物治疗实体瘤患者出现心脏毒性后,继续使用S-1进行氟尿嘧啶类药物治疗:一项多中心回顾性观察队列研究
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2022.100427
Osterlund, P; Kinos, S; Pfeiffer, P; Salminen, T; Kwakman, J J M; Frödin, J-E; Shah, C H; Sorbye, H; Ristamäki, R; Halonen, P; Soveri, L M; Heervä, E; Ålgars, A; Bärlund, M; Hagman, H; McDermott, R; O'Reilly, M; Röckert, R; Liposits, G; Kallio, R; Flygare, P; Teske, A J; van Werkhoven, E; Punt, C J A; Glimelius, B